Gene: P2ry10 (P2Y receptor family member 10) Rattus norvegicus
Analyze
Symbol: P2ry10
Name: P2Y receptor family member 10
Description: Predicted to have G protein-coupled receptor activity; predicted to be involved in positive regulation of Rho protein signal transduction and positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway; predicted to localize to the integral component of plasma membrane; orthologous to human P2RY10 (P2Y receptor family member 10); INTERACTS WITH (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE; aflatoxin B1; bisphenol A.
Type: protein-coding
RefSeq Status: PROVISIONAL
Also known as: LOC317219; MGC189289; purinergic receptor P2Y, G-protein coupled 10 ; purinergic receptor P2Y, G-protein coupled, 10; purinergic receptor P2Y10; putative P2Y purinoceptor 10; RGD1561912; similar to purinergic receptor P2Y, G-protein coupled 10
Orthologs:
Latest Assembly: Rnor_6.0 - RGSC Genome Assembly v6.0
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Rnor_6.0X78,158,729 - 78,210,413 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.0X78,356,095 - 78,408,236 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4X95,343,559 - 95,357,672 (+)NCBIRGSC3.4rn4RGSC3.4
CeleraX73,487,770 - 73,501,883 (+)NCBICelera
Cytogenetic MapXq22NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


References - curated
References - uncurated
RGD Disease Portals

Genomics

Comparative Map Data
QTLs in Region (Rnor_6.0)
miRNA Target Status

Sequence

Nucleotide Sequences
Protein Sequences
Transcriptome

Strain Variation

Strain Sequence Variants (Rnor 5.0)

Additional Information

External Database Links
Nomenclature History
 
More on P2ry10
Alliance Gene
NCBI Gene
Ensembl Gene
JBrowse: rn5 rn6
NCBI Genome Data Viewer

RGD Object Information
RGD ID: 1561912
Created: 2006-02-09
Species: Rattus norvegicus
Last Modified: 2019-04-12
Status: ACTIVE



NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.